Skip to main content

MPLKIP KO cell lysate available now. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 1 and Insertion of the selection cassette in exon 1.

Be the first to review this product! Submit a review

Images

Sanger Sequencing - Human MPLKIP (TTDN1) knockout HeLa cell lysate (AB258050), expandable thumbnail
  • Sanger Sequencing - Human MPLKIP (TTDN1) knockout HeLa cell lysate (AB258050), expandable thumbnail

Key facts

Cell type
HeLa
Species or organism
Human
Tissue
Cervix
Knockout validation
Sanger Sequencing
Mutation description
Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 1 and Insertion of the selection cassette in exon 1.

Alternative names

What's included?

1 Kit
Components
Human MPLKIP knockout HeLa cell lysate
1 x 100 µg
Human wild-type HeLa cell lysate
1 x 100 µg

Recommended products

MPLKIP KO cell lysate available now. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 1 and Insertion of the selection cassette in exon 1.

Key facts

Cell type
HeLa
Mutation description
Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 1 and Insertion of the selection cassette in exon 1.
Disease
Adenocarcinoma
Concentration
Loading...

Properties

Gene name
MPLKIP
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing

Quality control

STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female

Storage

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Notes


Knockout cell lysate achieved by CRISPR/Cas9.

Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

TTDN1 also known as C20orf174 is a protein involved in cellular processes that facilitate DNA repair. It weighs approximately 47 kilodaltons and is expressed in various tissues with higher levels observed in testis and ovary. The protein plays an essential role in maintaining genomic integrity by interacting with specific components of the DNA repair machinery.

Biological function summary

TTDN1 contributes to the repair of double-strand DNA breaks. It forms part of the larger DNA repair complex which recruits and coordinates other proteins needed for effective DNA repair. This function is especially important in cells exposed to frequent DNA damage supporting cellular stability and proper functioning by ensuring accurate DNA replication and transmission.

Pathways

The functions of TTDN1 intersect with the homologous recombination and non-homologous end joining pathways. It interacts with proteins such as BRCA1 and RAD51 which are key in DNA damage response and repair. These pathways enable cells to prevent mutations therefore safeguarding the genome's integrity during cell division and proliferation.

Associated diseases and disorders

TTDN1 is associated with trichothiodystrophy a condition characterized by defects in DNA repair mechanisms. This association suggests TTDN1's involvement in clinical presentations linked to DNA repair deficiencies. Additionally anomalies in proteins like ERCC2 which also participates in DNA repair may exacerbate the effects when TTDN1 function is impaired leading to more severe disease outcomes.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Sanger Sequencing - Human MPLKIP (TTDN1) knockout HeLa cell lysate (ab258050), expandable thumbnail

    Sanger Sequencing - Human MPLKIP (TTDN1) knockout HeLa cell lysate (ab258050)

    Allele-2: 1 bp deletion in exon 1

  • Sanger Sequencing - Human MPLKIP (TTDN1) knockout HeLa cell lysate (ab258050), expandable thumbnail

    Sanger Sequencing - Human MPLKIP (TTDN1) knockout HeLa cell lysate (ab258050)

    Allele-1: Insertion of the selection cassette in exon 1

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com